ID

31141

Description

A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy.; ODM derived from: https://clinicaltrials.gov/show/NCT00773383

Lien

https://clinicaltrials.gov/show/NCT00773383

Mots-clés

  1. 23/07/2018 23/07/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

23 juillet 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Non-Small Cell Lung Cancer NCT00773383

Eligibility Non-Small Cell Lung Cancer NCT00773383

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female patients >=18 years with histologically documented inoperable, locally advanced or metastatic (stage iiib or iv) nsclc;
Description

Age | Non-Small Cell Lung Carcinoma Inoperable TNM clinical staging | Non-Small Cell Lung Carcinoma Advanced Locally TNM clinical staging | Non-small cell lung cancer metastatic TNM clinical staging

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0007131
UMLS CUI [2,2]
C0205187
UMLS CUI [2,3]
C3258246
UMLS CUI [3,1]
C0007131
UMLS CUI [3,2]
C0205179
UMLS CUI [3,3]
C1517927
UMLS CUI [3,4]
C3258246
UMLS CUI [4,1]
C0278987
UMLS CUI [4,2]
C3258246
currently receiving tarceva monotherapy and having failed at least one standard chemotherapy regimens;
Description

Tarceva | Standard Chemotherapy Quantity failed

Type de données

boolean

Alias
UMLS CUI [1]
C1135136
UMLS CUI [2,1]
C1442989
UMLS CUI [2,2]
C0392920
UMLS CUI [2,3]
C1265611
UMLS CUI [2,4]
C0231175
prior response or stable disease 12 weeks from start of tarceva;
Description

Tarceva | Response Previous | Stable Disease Previous

Type de données

boolean

Alias
UMLS CUI [1]
C1135136
UMLS CUI [2,1]
C1704632
UMLS CUI [2,2]
C0205156
UMLS CUI [3,1]
C0677946
UMLS CUI [3,2]
C0205156
documented progressive disease at enrollment;
Description

Progressive Disease

Type de données

boolean

Alias
UMLS CUI [1]
C1335499
measurable disease according to the recist criteria;
Description

Measurable Disease

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
ecog performance status 0-2;
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy >12 weeks.
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with active cns lesions;
Description

Central nervous system lesion

Type de données

boolean

Alias
UMLS CUI [1]
C0742468
prior treatment with agents acting via igf-1r inhibition or egfr targeting;
Description

IGF-1R inhibitors | EGFR Targeted Therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C4044495
UMLS CUI [1,2]
C0243077
UMLS CUI [2,1]
C0034802
UMLS CUI [2,2]
C2985566
administration with high doses of systemic corticosteroids;
Description

CORTICOSTEROIDS FOR SYSTEMIC USE High dose

Type de données

boolean

Alias
UMLS CUI [1,1]
C3653708
UMLS CUI [1,2]
C0444956
radiotherapy in the 4 weeks prior to study start;
Description

Therapeutic radiology procedure

Type de données

boolean

Alias
UMLS CUI [1]
C1522449
surgery or significant traumatic injury with in the last 2 weeks prior to study start.
Description

Operative Surgical Procedures | Traumatic injury

Type de données

boolean

Alias
UMLS CUI [1]
C0543467
UMLS CUI [2]
C3263723

Similar models

Eligibility Non-Small Cell Lung Cancer NCT00773383

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age | Non-Small Cell Lung Carcinoma Inoperable TNM clinical staging | Non-Small Cell Lung Carcinoma Advanced Locally TNM clinical staging | Non-small cell lung cancer metastatic TNM clinical staging
Item
male or female patients >=18 years with histologically documented inoperable, locally advanced or metastatic (stage iiib or iv) nsclc;
boolean
C0001779 (UMLS CUI [1])
C0007131 (UMLS CUI [2,1])
C0205187 (UMLS CUI [2,2])
C3258246 (UMLS CUI [2,3])
C0007131 (UMLS CUI [3,1])
C0205179 (UMLS CUI [3,2])
C1517927 (UMLS CUI [3,3])
C3258246 (UMLS CUI [3,4])
C0278987 (UMLS CUI [4,1])
C3258246 (UMLS CUI [4,2])
Tarceva | Standard Chemotherapy Quantity failed
Item
currently receiving tarceva monotherapy and having failed at least one standard chemotherapy regimens;
boolean
C1135136 (UMLS CUI [1])
C1442989 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0231175 (UMLS CUI [2,4])
Tarceva | Response Previous | Stable Disease Previous
Item
prior response or stable disease 12 weeks from start of tarceva;
boolean
C1135136 (UMLS CUI [1])
C1704632 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
C0677946 (UMLS CUI [3,1])
C0205156 (UMLS CUI [3,2])
Progressive Disease
Item
documented progressive disease at enrollment;
boolean
C1335499 (UMLS CUI [1])
Measurable Disease
Item
measurable disease according to the recist criteria;
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-2;
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy >12 weeks.
boolean
C0023671 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Central nervous system lesion
Item
patients with active cns lesions;
boolean
C0742468 (UMLS CUI [1])
IGF-1R inhibitors | EGFR Targeted Therapy
Item
prior treatment with agents acting via igf-1r inhibition or egfr targeting;
boolean
C4044495 (UMLS CUI [1,1])
C0243077 (UMLS CUI [1,2])
C0034802 (UMLS CUI [2,1])
C2985566 (UMLS CUI [2,2])
CORTICOSTEROIDS FOR SYSTEMIC USE High dose
Item
administration with high doses of systemic corticosteroids;
boolean
C3653708 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
Therapeutic radiology procedure
Item
radiotherapy in the 4 weeks prior to study start;
boolean
C1522449 (UMLS CUI [1])
Operative Surgical Procedures | Traumatic injury
Item
surgery or significant traumatic injury with in the last 2 weeks prior to study start.
boolean
C0543467 (UMLS CUI [1])
C3263723 (UMLS CUI [2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial